Antibodies News and Research

RSS

IONTAS collaborates with LG Chem to discover antibodies for treating cancer

IONTAS Limited, a leader in the discovery and optimisation of fully human antibodies, today announced it has signed a collaboration agreement with Korean-based LG Chem, Ltd. for the discovery of therapeutic antibodies targeting undisclosed targets for use in the treatment of cancers.

5 Jun 2018

Altering bacteria’s genetic code may pave way for long-lasting drugs, shows study

By altering the genetic code in bacteria, researchers at The University of Texas at Austin have demonstrated a method to make therapeutic proteins more stable, an advance that would improve the drugs' effectiveness and convenience, leading to smaller and less frequent doses of medicine, lower health care costs and fewer side effects for patients with cancer and other diseases.

5 Jun 2018

Researchers find novel gene in red blood cells that may help limb regeneration in adult newts

Newts are the only four-legged vertebrates that can regenerate their body parts even as adults. When a newt loses a limb, a mass of cells, called a blastema, is generated at the stump, from which a new, fully functional limb is eventually regenerated.

5 Jun 2018

Phase I trial shows safety of investigational drug in treating chronic lymphocytic leukemia

Reporting results from a first-in-human phase I clinical trial, researchers at University of California San Diego School of Medicine have found that treatment with cirmtuzumab, an experimental monoclonal antibody-based drug, measurably inhibited the "stemness" of chronic leukemia cancer cells - their ability to self-renew and resist terminal differentiation and senescence.

1 Jun 2018

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Bristol-Myers Squibb Company today announced patient-reported outcomes data from the Phase 3 CheckMate -214 trial in intermediate- and poor-risk patients with advanced renal cell carcinoma treated with the Immuno-Oncology combination Opdivo plus low-dose Yervoy versus sunitinib over a two-year follow-up period.

1 Jun 2018

Discovering Antibodies with Universal Specificity

Professor Hedda Wardemann discusses our current knowledge of antibody specificity and how her research team are challenging this, through the discovery of anti-bacterial antibodies with universal specificity.

1 Jun 2018

Bacterium causing nosocomial infections uses tiny finger-like structures to infect medical tools

The antibiotic-resistant Acinetobacter baumannii bacterium is one of the most globally harmful bacteria that causes nosocomial infections.

1 Jun 2018

Scientists engineer bi-specific antibodies that attract immune killers directly to cancer cells

Our immune system's arsenal of defenses usually protects us from cancer. But sometimes, cancer cells overwhelm or evade this elaborate defense system.

30 May 2018

Miniaturized device offers new way to gain insight into cell processes and communication

Like humans, cells of the same species each have a distinct "personality." When confronted with an external stimulus like a virus, they each secrete a different quantity of molecules and communicate with each other to a varying degree.

28 May 2018

AARDA collaborates with Allegheny Health Network and new AHN Autoimmunity Institute

The American Autoimmune Related Diseases Association is proud and honored to announce its collaborative partnership with Allegheny Health Network and its new Autoimmunity Institute.

25 May 2018

Lyme disease researcher dispels misconceptions about ticks and provides prevention tips

Lyme disease is now the most reported vector-borne disease in the United States and the CDC released a report showing that diseases from biting insects, ticks, and mosquitos in the U.S. have tripled since 2004.

25 May 2018

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

The U.S. Food and Drug Administration today approved Palynziq (pegvaliase-pqpz) for adults with a rare and serious genetic disease known as phenylketonuria (PKU).

25 May 2018

NIH commences first-in-human trial evaluating experimental treatment for Ebola

A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland.

24 May 2018

Comparative Analysis of a Complex Monoclonal Antibody

Postnova Analytics has published a new poster that compares the suitability of Electrical Asymmetrical Flow Field Flow Fractionation (EAF4) and Size Exclusion Chromatography (SEC) for determining the physicochemical and biophysical attributes of monoclonal antibodies.

From Postnova Analytics 23 May 2018

Determining the Optimal Biomarker Frequency for Biosensors

Chi-En Lin won Metrohm’s Young Chemist of the Year award for research into optimal biomarker frequencies and how it can be applied.

From Metrohm USA Inc. 22 May 2018

Researcher develops nanoparticle-based tags to detect viruses and cancer with high sensitivity

How can we detect cancer and viruses with high sensitivity? Physical chemist Laura Fabris-;an associate professor in the Materials Science and Engineering Department at Rutgers, the State University of New Jersey, and principal investigator of the Fabris NanoBio Group-;is addressing this very question.

22 May 2018

Researchers to test two-pronged approach in humans to treat advanced colorectal cancer

For the first time in humans, researchers will test a two-pronged approach to treat advanced stage colorectal cancer, potentially increasing life expectancy.

22 May 2018

Pfizer starts Phase 1/2 study of RSV vaccine candidate in healthy adult volunteers

Pfizer Inc. today announced that it has started a Phase 1/2 trial of its respiratory syncytial virus (RSV) vaccine candidate in healthy adult volunteers. RSV is a common respiratory virus that affects the lungs and airways, with significant impact on young children and older adults.

22 May 2018

DNA vaccine shows promise for colorectal cancer

For the first time in humans, researchers are testing a combined approach to treating advanced stage colorectal cancer (CRC) that may be life-changing for patients.

22 May 2018

Scientists identify new drug target to combat chikungunya virus

Scientists have identified a molecule found on human cells and some animal cells that could be a useful target for drugs against chikungunya virus infection and related diseases, according to new research published in the journal Nature.

21 May 2018

Antibodies News and Research

IONTAS collaborates with LG Chem to discover antibodies for treating cancer

Altering bacteria’s genetic code may pave way for long-lasting drugs, shows study

Researchers find novel gene in red blood cells that may help limb regeneration in adult newts

Phase I trial shows safety of investigational drug in treating chronic lymphocytic leukemia

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Discovering Antibodies with Universal Specificity

Bacterium causing nosocomial infections uses tiny finger-like structures to infect medical tools

Scientists engineer bi-specific antibodies that attract immune killers directly to cancer cells

Miniaturized device offers new way to gain insight into cell processes and communication

AARDA collaborates with Allegheny Health Network and new AHN Autoimmunity Institute

Lyme disease researcher dispels misconceptions about ticks and provides prevention tips

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

NIH commences first-in-human trial evaluating experimental treatment for Ebola

Comparative Analysis of a Complex Monoclonal Antibody

Determining the Optimal Biomarker Frequency for Biosensors

Researcher develops nanoparticle-based tags to detect viruses and cancer with high sensitivity

Researchers to test two-pronged approach in humans to treat advanced colorectal cancer

Pfizer starts Phase 1/2 study of RSV vaccine candidate in healthy adult volunteers

DNA vaccine shows promise for colorectal cancer

Scientists identify new drug target to combat chikungunya virus

Antibodies eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News